Sales & Marketing News | pharmaphorum

News

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both infringing patents its holds on a delive

News

AZ pays $775m to settle patent dispute with Chugai over Ulto...

AstraZeneca has resolved a lingering liability following its takeover of Alexion with an agreement to pay $775 million to settle a patent dispute with Chugai Pharma, Roche's Japanese subsid

News

Update: FDA clears first generic of AZ's blockbuster Symbico...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain

News

Eisai hands off responsibility for Aduhelm to Biogen

Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen for troubled Alzheimer's therapy Aduhelm, handing over full responsibility to its US counterpart.

News

Sandoz bulks up ahead of possible sale with Coalesce buy

Novartis may be planning to sell off its generics business Sandoz, but that hasn't stopped it investing in the unit ahead of a decision on its future later this year.

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

Mallinckrodt pays $260m to settle kickback, rebate fraud cha...

Mallinckrodt's liability problems in the US have been lightened slightly, after it agreed a $260 million deal to resolve allegations of Medicare rebate fraud and payment of illegal kickback

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

AZ pays $775m to settle patent dispute with Chugai over Ulto...

Update: FDA clears first generic of AZ's blockbuster Symbico...

Eisai hands off responsibility for Aduhelm to Biogen

Sandoz bulks up ahead of possible sale with Coalesce buy

Mallinckrodt pays $260m to settle kickback, rebate fraud cha...

Trustworthy and novel AI in clinical trial planning, with Kr...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks